Loss-of-function assays showed that silencing SAPCD2 not only attenuated the proliferation and promoted the apoptosis of fibrosarcoma cells in vitro, but also inhibited the lung metastasis of fibrosarcoma cells in vivo. Here, SAPCD2 is linked to fibrosarcoma.